Home
>
National Drug Code (NDC)
>
Metoprolol
Metoprolol - 25021-303-05 - (metoprolol tartrate)
Drug Information of Metoprolol
| Product NDC: | 25021-303 |
| Proprietary Name: | Metoprolol |
| Non Proprietary Name: | metoprolol tartrate |
| Active Ingredient(s): | 5 mg/5mL & nbsp; metoprolol tartrate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Metoprolol
| Product NDC: | 25021-303 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090317 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100510 |
Package Information of Metoprolol
| Package NDC: | 25021-303-05 |
| Package Description: | 10 VIAL in 1 CARTON (25021-303-05) > 5 mL in 1 VIAL |
NDC Information of Metoprolol
| NDC Code | 25021-303-05 |
| Proprietary Name | Metoprolol |
| Package Description | 10 VIAL in 1 CARTON (25021-303-05) > 5 mL in 1 VIAL |
| Product NDC | 25021-303 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metoprolol tartrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20100510 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | METOPROLOL TARTRATE |
| Strength Number | 5 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
